🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Mario Gabelli’s VRTX Holdings & Trades

First Buy
Q2 2025
Duration Held
4 Quarters
Largest Add
Q2 2025
+512 Shares
Current Position
400 Shares
$209,124 Value

Mario Gabelli's VRTX Position Overview

Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 400 shares of Vertex Pharmaceuticals Incorporated (VRTX) worth $209,124, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.

Based on 13F filings, Mario Gabelli has maintained this position in VRTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 400 shares. Largest reduction occurred in Q4 2025, reducing 512 shares.

Analysis based on 13F filings available since 2013 Q2

Mario Gabelli's Vertex Pharmaceuticals Incorporated (VRTX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Vertex Pharmaceuticals Incorporated (VRTX) Trades by Mario Gabelli

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +400 New Buy 400 $522.81
Q4 2025 -512 Sold Out 0 $0.00
Q2 2025 +512 New Buy 512 $445.20

Mario Gabelli's Vertex Pharmaceuticals Incorporated Investment FAQs

Mario Gabelli first purchased Vertex Pharmaceuticals Incorporated (VRTX) in Q2 2025, acquiring 512 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Mario Gabelli has held Vertex Pharmaceuticals Incorporated (VRTX) for 4 quarters since Q2 2025.

Mario Gabelli's largest addition to Vertex Pharmaceuticals Incorporated (VRTX) was in Q2 2025, adding 512 shares worth $227,942.

According to the latest 13F filing for Q3 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 400 shares of Vertex Pharmaceuticals Incorporated (VRTX), valued at approximately $209,124.

As of the Q3 2026 filing, Vertex Pharmaceuticals Incorporated (VRTX) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.

Mario Gabelli's peak holding in Vertex Pharmaceuticals Incorporated (VRTX) was 512 shares, as reported at the end of Q2 2025.